IM Cannabis (IMCC) Non-Current Deferred Tax Liability (2019 - 2026)
IM Cannabis (IMCC) posted quarterly Non-Current Deferred Tax Liability of $213657.3 for Q1 2026, down 32.32% year-over-year from $315703.2 in Q1 2025, and down 16.07% quarter-over-quarter from $254565.6 in Q4 2025.
IM Cannabis (IMCC) Non-Current Deferred Tax Liability (2019 - 2026) Analysis & Trends
IM Cannabis' Non-Current Deferred Tax Liability history runs 8 years deep, the most recent figure standing at $213657.3 for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 32.32% year-over-year to $213657.3; the TTM figure through Mar 2026 stood at $213657.3 (down 32.32% YoY), while the FY2025 annual figure was $254565.6, down 28.43% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $213657.3, down from $254565.6 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $5.0 million in Q1 2022, with the low at $213657.3 in Q1 2026.
- The 5-year median for Non-Current Deferred Tax Liability is $669386.1 (2024), against an average of $1.0 million.
- The sharpest annual moves came in 2023 and 2025: Non-Current Deferred Tax Liability tumbled 81.41% in 2023, then retreated 19.31% in 2025.
- IM Cannabis' Non-Current Deferred Tax Liability stood at $981288.3 in 2022, then declined by 27.92% to $707357.7 in 2023, then tumbled by 50.72% to $348618.5 in 2024, then dropped by 26.98% to $254565.6 in 2025, then dropped by 16.07% to $213657.3 in 2026.
- Business Quant data shows IMCC's Non-Current Deferred Tax Liability at $213657.3 in Q1 2026, $254565.6 in Q4 2025, and $290654.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 200,250.30 |
| Jun 30, 2026 | 200,250.30 |
| Mar 31, 2026 | 213,657.27 |
| Mar 31, 2026 | 213,657.27 |
| Dec 31, 2025 | 254,565.63 |
| Dec 31, 2025 | 254,565.63 |
| Sep 30, 2025 | 290,654.00 |
| Sep 30, 2025 | 290,654.00 |
| Jun 30, 2025 | 310,336.37 |
| Jun 30, 2025 | 310,336.37 |
| Mar 31, 2025 | 315,703.16 |
| Mar 31, 2025 | 315,703.16 |
| Dec 31, 2024 | 348,618.53 |
| Dec 31, 2024 | 348,618.53 |
| Sep 30, 2024 | 367,992.81 |
| Sep 30, 2024 | 367,992.81 |
| Jun 30, 2024 | 384,579.93 |
| Jun 30, 2024 | 384,579.93 |
| Mar 31, 2024 | 669,386.11 |
| Mar 31, 2024 | 669,386.11 |